The pleiotropic role of thymic stromal lymphopoietin (TSLP) in immune homeostasis and disease

I. Biological Characteristics and Immunoregulatory Functions of TSLP

Thymic Stromal Lymphopoietin (TSLP) is a key cytokine expressed in epithelial cells and various stromal cells, playing a central role in maintaining mucosal barrier immune homeostasis and regulating inflammatory responses. TSLP signaling is primarily mediated through a heterodimeric receptor complex composed of the TSLP receptor (TSLPR) and the IL-7 receptor α-chain (IL-7Rα). Initially, TSLP was extensively studied for its pivotal role in initiating and driving type 2 immune responses (Th2), as it can directly act on dendritic cells (DCs), promoting their maturation and inducing the differentiation of naïve T cells into Th2 cells, while also activating innate lymphoid cells, mast cells, and other immune cells.

II. Role of TSLP in Allergic and Inflammatory Diseases

Dysregulation of TSLP is closely associated with various barrier tissue-related allergic and inflammatory diseases, and its genetic polymorphisms have been confirmed as significant risk factors for disease susceptibility.

1. Atopic Dermatitis: In patients with atopic dermatitis, TSLP expression is significantly upregulated in both acute and chronic lesions, with levels correlating with disease severity and epidermal barrier dysfunction. Genetic studies indicate that specific TSLP gene variants (e.g., rs1898671) are linked to disease persistence and severity.

2. Asthma: As a critical regulator of respiratory barriers, TSLP plays a key role in the pathogenesis of asthma. Large-scale genome-wide association studies have confirmed that TSLP single nucleotide polymorphisms (e.g., rs1837253) are significant risk loci for asthma across diverse ethnic populations.

3. Food Allergy and Eosinophilic Esophagitis: While direct associations between TSLP gene variants and peanut allergy remain unclear, TSLP has been identified as a major genetic risk locus for food allergy-related conditions such as eosinophilic esophagitis, highlighting its importance in gastrointestinal barrier immune regulation.

III. The Complex Role of TSLP in the Tumor Immune Microenvironment

Recent studies have revealed that TSLP's biological functions extend beyond type 2 immunity, exhibiting a complex and context-dependent dual role in tumor development.

1. Promoting Tumor Progression: In various solid tumors (e.g., pancreatic, gastric, ovarian, and breast cancers), tumor cells or cancer-associated fibroblasts (CAFs) can secrete TSLP. Tumor-derived IL-1α/β can induce CAFs to express TSLP, which then acts on immune cells such as dendritic cells in the tumor microenvironment, promoting a Th2-biased immune response that may impair effective anti-tumor immunity and is associated with poor prognosis. Additionally, TSLP can directly act on vascular endothelial cells to promote tumor angiogenesis or upregulate anti-apoptotic proteins (e.g., Bcl-2, Bcl-xL) in tumor cells to enhance their survival.

2. Potential Anti-Tumor Effects: Some studies suggest that in certain tumor types or specific contexts, TSLP may also exert anti-tumor effects by activating specific immune responses. Whether TSLP ultimately promotes or suppresses tumors likely depends on tumor type, microenvironment composition, and spatiotemporal specificity of signaling.

IV. The Value of TSLP Protein as a Research Tool and Future Perspectives

To elucidate the precise molecular mechanisms of TSLP in the aforementioned diseases and advance the development of targeted therapies, high-purity, functionally intact TSLP His Tag Protein is an indispensable core research tool. This recombinant protein can be used for:

1. In Vitro Functional and Mechanistic Studies: Stimulating target cells such as DCs, T cells, and endothelial cells to investigate TSLP's effects on cell differentiation, proliferation, apoptosis, migration, and cytokine secretion, as well as elucidating downstream signaling pathways (e.g., JAK-STAT).

2. Receptor Interaction and Signaling Analysis: Studying its binding properties and affinity with the TSLPR/IL-7Rα receptor complex.

3. Disease Model Construction: Exogenous application of TSLP protein in animal models to mimic its pathological roles in allergy, inflammation, or the tumor microenvironment.

4. Drug Screening and Evaluation: As a target protein, for screening and evaluating the bioactivity and potency of anti-TSLP antibodies (e.g., tezepelumab) or other inhibitors.

V. Future Perspectives

The biological landscape of TSLP continues to expand. Clinical studies show that TSLP-targeting monoclonal antibodies (e.g., tezepelumab) are effective not only for eosinophilic asthma but also for preventing acute exacerbations in non-eosinophilic asthma, indicating TSLP signaling's critical role throughout disease progression and in non-type 2 inflammation. Additionally, TSLP co-stimulation with CD40 can induce DCs to produce IL-23, suggesting its potential function in Th17-type inflammation. Future research using tools like TSLP His Tag Protein will further clarify TSLP's specific mechanisms in different tumor types and inflammatory cascades, providing a solid scientific foundation for extending TSLP-targeted therapies from allergic diseases to broader fields such as oncology.

VI. Which Manufacturers Provide TSLP His Tag Protein?

Nanjing U-Protein Biotechnology has independently developed TSLP His Tag Protein, Human (Catalog No.: UA011336), a high-purity, high-activity recombinant human thymic stromal lymphopoietin (TSLP) protein. It is produced using a mammalian expression system and carries a C-terminal His tag for easy purification and detection. TSLP is a key cytokine initiating type 2 immune responses and plays a central role in allergic diseases, asthma, and skin inflammation. This product is suitable for immune regulation research, drug screening, and cell function experiments, offering a reliable and efficient research tool.

Nanjing U-Protein Biotechnology is committed to providing high-quality, high-performance recombinant protein tools for immunology, allergic disease research, and innovative drug development. For detailed technical parameters, binding activity data, or application guidance on TSLP His Tag Protein, Human (Catalog No.: UA011336), please feel free to contact us.